Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZTREONAM LYSINE Cause Visual impairment? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Visual impairment have been filed in association with AZTREONAM LYSINE. This represents 0.1% of all adverse event reports for AZTREONAM LYSINE.

13
Reports of Visual impairment with AZTREONAM LYSINE
0.1%
of all AZTREONAM LYSINE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Visual impairment From AZTREONAM LYSINE?

Of the 13 reports, 3 (23.1%) required hospitalization.

Is Visual impairment Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZTREONAM LYSINE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does AZTREONAM LYSINE Cause?

Cystic fibrosis (2,766) Off label use (1,398) Pneumonia (1,180) Death (1,061) Infection (760) Lung disorder (543) Lung transplant (499) Cystic fibrosis respiratory infection suppression (440) Condition aggravated (431) Dyspnoea (391)

What Other Drugs Cause Visual impairment?

INSULIN GLARGINE (5,793) INSULIN LISPRO (4,654) ADALIMUMAB (3,770) DUPILUMAB (3,089) ETANERCEPT (2,489) FINGOLIMOD (2,147) AFLIBERCEPT (1,836) PREGABALIN (1,714) METHOTREXATE (1,588) TOFACITINIB (1,544)

Which AZTREONAM LYSINE Alternatives Have Lower Visual impairment Risk?

AZTREONAM LYSINE vs BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN AZTREONAM LYSINE vs BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN AZTREONAM LYSINE vs BACITRACIN AZTREONAM LYSINE vs BACITRACIN\NEOMYCIN\POLYMYXIN B AZTREONAM LYSINE vs BACITRACIN\POLYMYXIN B

Related Pages

AZTREONAM LYSINE Full Profile All Visual impairment Reports All Drugs Causing Visual impairment AZTREONAM LYSINE Demographics